{"id":"https://openalex.org/W2149689509","doi":null,"title":"Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.","display_name":"Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.","publication_year":1991,"publication_date":"1991-02-15","ids":{"openalex":"https://openalex.org/W2149689509","mag":"2149689509","pmid":"https://pubmed.ncbi.nlm.nih.gov/1997159"},"language":"en","primary_location":{"id":"pmid:1997159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084162637","display_name":"Giacinta Del Bino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169071179","display_name":"Cancer Research Institute","ror":"https://ror.org/02f3xk561","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I169071179"]},{"id":"https://openalex.org/I181190671","display_name":"New York Medical College","ror":"https://ror.org/03dkvy735","country_code":"US","type":"education","lineage":["https://openalex.org/I181190671"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G Del Bino","raw_affiliation_strings":["Cancer Research Institute, New York Medical College, Valhalla 10595"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research Institute, New York Medical College, Valhalla 10595","institution_ids":["https://openalex.org/I169071179","https://openalex.org/I181190671"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086304089","display_name":"Zbigniew Dar\u017cynkiewicz","orcid":"https://orcid.org/0000-0002-2040-7081","observed_orcids":["https://orcid.org/0000-0002-2040-7081"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Darzynkiewicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7838,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.96419264,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"51","issue":"4","first_page":"1165","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/camptothecin","display_name":"camptothecin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/teniposide","display_name":"teniposide","score":0.9800000190734863},{"id":"https://openalex.org/keywords/amsacrine","display_name":"amsacrine","score":0.9739999771118164},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8859999775886536},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":1.0},{"id":"https://openalex.org/keywords/dna-degradation","display_name":"DNA degradation","score":0.781000018119812},{"id":"https://openalex.org/keywords/s-phase","display_name":"S phase","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hl-60-cells","display_name":"HL-60 cells","score":0.9670000076293945},{"id":"https://openalex.org/keywords/molt-4-cells","display_name":"MOLT-4 cells","score":0.9879999756813049},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.703000009059906},{"id":"https://openalex.org/keywords/lymphocytic-leukemia","display_name":"lymphocytic leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.7870000004768372},{"id":"https://openalex.org/keywords/dna-ploidy","display_name":"DNA ploidy","score":0.8399999737739563},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.33399999141693115},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C2778707968","wikidata":"https://www.wikidata.org/wiki/Q417555","display_name":"Teniposide","level":4,"score":0.9737842679023743},{"id":"https://openalex.org/C2780500152","wikidata":"https://www.wikidata.org/wiki/Q2784004","display_name":"Amsacrine","level":4,"score":0.9603161811828613},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.8687173128128052},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.8198438882827759},{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.8148744106292725},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4737713634967804},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4595370292663574},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4554561674594879},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4547010660171509},{"id":"https://openalex.org/C2778143360","wikidata":"https://www.wikidata.org/wiki/Q421193","display_name":"Podophyllotoxin","level":2,"score":0.4493454396724701},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3921622335910797},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.3641864061355591},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.36039474606513977},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33137959241867065},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25439733266830444},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12438881397247314},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0980578064918518},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000677","descriptor_name":"Amsacrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013713","descriptor_name":"Teniposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016196","descriptor_name":"S Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1997159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2149689509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1997159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6634477436","display_name":"Probes for Cytometry","funder_award_id":"R01CA028704","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6747171896","display_name":"EFFECTS OF NEW ANTICANCER DRUGS ON THE CELL CYCLE","funder_award_id":"R37CA023296","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W123654701","https://openalex.org/W1514525963","https://openalex.org/W1539572069","https://openalex.org/W1548535221","https://openalex.org/W1549846058","https://openalex.org/W1607928595","https://openalex.org/W1705636341","https://openalex.org/W1782640926","https://openalex.org/W1964421187","https://openalex.org/W2013650054","https://openalex.org/W2024931691","https://openalex.org/W2035215935","https://openalex.org/W2037902796","https://openalex.org/W2062241630","https://openalex.org/W2109772984","https://openalex.org/W2112902082","https://openalex.org/W2118553080","https://openalex.org/W2119687650","https://openalex.org/W2130039633","https://openalex.org/W2142153650","https://openalex.org/W2159921901","https://openalex.org/W2394674068"],"related_works":["https://openalex.org/W1519382583","https://openalex.org/W1964421187","https://openalex.org/W1539572069","https://openalex.org/W2096253938","https://openalex.org/W1636279715","https://openalex.org/W1982329776","https://openalex.org/W2397832350","https://openalex.org/W2004085522","https://openalex.org/W2032450695","https://openalex.org/W2066828524"],"abstract_inverted_index":{"Short-term":[0],"(2-6":[1],"h)":[2],"exposure":[3],"of":[4,37,46,50,102,141,172,179,216,225],"human":[5,94],"promyelocytic":[6],"HL-60":[7,82,92,180],"cell":[8,202],"cultures":[9],"to":[10,20,91,100,150,182,197,219],"the":[11,21,47,61,136,139,160,167,211,226,235],"DNA":[12,38,75,130,152,190],"topoisomerase":[13,22,153],"I":[14,154],"inhibitor":[15],"camptothecin":[16],"(0.05-0.5":[17],"microgram/ml)":[18,33,66],"or":[19,29,67,185,199],"II":[23,156],"inhibitor,":[24],"teniposide":[25],"(VM-26;":[26],"0.3-3.0":[27],"micrograms/ml)":[28,71],"4'-(9-acridinylamino)methanesulfon-m-anisidide":[30],"(amsacrine;":[31],"0.8":[32],"triggered":[34,189],"rapid":[35],"degradation":[36,76,191],"specifically":[39],"in":[40,57,77,84,119,138,144,192,204,234],"S-phase":[41,51,142],"cells.":[42],"As":[43],"a":[44,128],"result":[45],"selective":[48],"death":[49],"cells,":[52,93],"only":[53],"G1":[54],"cells":[55,83,98,143,181],"remained":[56],"these":[58,103,173,220],"cultures.":[59],"On":[60],"other":[62],"hand,":[63],"mitoxantrone":[64,198],"(0.02-0.4":[65],"doxorubicin":[68],"(adriamycin;":[69],"0.4-10.0":[70],"did":[72],"not":[73],"induce":[74],"S":[78,85,122,193],"phase":[79],"but":[80],"arrested":[81,118],"and":[86,109,121,124,155,158,169,206],"G2":[87,120,205],"phases.":[88],"In":[89],"contrast":[90],"lymphocytic":[95,147],"leukemic":[96,148],"MOLT-4":[97],"responded":[99],"all":[101,112],"drugs":[104,221],"(camptothecin,":[105],"teniposide,":[106,184],"amsacrine,":[107],"mitoxantrone,":[108],"adriamycin)":[110],"at":[111],"concentrations":[113],"tested,":[114],"invariably":[115],"by":[116,126,237],"being":[117],"phases":[123],"also":[125],"entering":[127],"higher":[129],"ploidy":[131],"cycle.":[132],"The":[133,175],"data":[134],"illustrate":[135],"differences":[137,233],"sensitivity":[140],"myelogenous":[145],"versus":[146],"lines":[149],"both":[151],"inhibitors":[157],"emphasize":[159],"tissue":[161],"(leukemia":[162],"type)-specific":[163],"factors":[164],"that":[165],"modulate":[166],"cytostatic":[168],"cytotoxic":[170],"effects":[171],"inhibitors.":[174],"qualitatively":[176],"different":[177],"response":[178],"camptothecin,":[183],"amsacrine":[186],"(by":[187,201],"rapidly":[188],"phase)":[194],"as":[195],"compared":[196],"adriamycin":[200],"arrest":[203],"S)":[207],"suggests":[208],"that,":[209],"despite":[210],"generally":[212],"assumed":[213],"common":[214],"mode":[215],"action":[217],"attributed":[218],"(i.e.,":[222],"via":[223],"stabilization":[224],"cleavable":[227],"DNA-topoisomerase":[228],"complexes),":[229],"there":[230],"are":[231],"significant":[232],"mechanisms":[236],"which":[238],"they":[239],"exert":[240],"cytostatic/cytotoxic":[241],"effects.":[242]},"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}